Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2022-05-16

Clinical Trial Update: Chemoradiotherapy Combined With or Without PD-1 Blockade in Anal Canal Squamous Carcinoma Patients [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating chemoradiotherapy with or without PD-1 blockade for anal canal squamous carcinoma; status currently unknown.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PD-1 blockade

Snippet

Sponsor: Sixth Affiliated Hospital, Sun Yat-sen University | Conditions: Anal Canal Cancer Stage III, Anal Squamous Cell Carcinoma | Phase 3 | Status: UNKNOWN